Corporate Banner
Satellite Banner
Technology Networks Header
Friday, April 25, 2014
 
Register | Sign in
Home Page>Products
  Product News
Sartorius Launches New Lab Balance on the Market
Wednesday, April 16, 2014
Quintix® is a user-friendly, highly accurate standard laboratory balance, redefining the meaning of easy for standard lab applications.

Efficient Delivery of Proteins into Living Cells
Tuesday, April 15, 2014
BioPORTER® protein delivery reagent from AMSBIO.

New Integrated Raman Spectroscopy & Imaging Software from CRAIC Technologies
Tuesday, April 15, 2014
CRAIC Technologies introduces Lambdafire-R™ integrated Raman microspectroscopy & imaging software for Windows 8 ®.

Porvair Completes Delivery of Major Hot Gas Filtration Contract
Tuesday, April 15, 2014
Company has successfully completed delivery of the Posco Energy char filter contract.

Cancer Researcher Wins Cytation™ 3 in BioTek's Contest!
Saturday, April 12, 2014
Dr. Jeff Peterson wins Cytation™ 3 cell imaging multi-mode reader in "Think Possible" Application Contest.

Analysis of Pesticides Present in Ayurvedic Churna by GC-MS/MS
Saturday, April 12, 2014
A sensitive and precise assay for the detection of pesticides.

Hevylite® FDA Cleared to Help Monitor Patients with IgG and IgA Myeloma
Friday, April 11, 2014
Hevylite® measures the concentration of each immunoglobulin subtype.

ERT Introduces GE Healthcare’s QT Guard Plus™ Analysis System
Friday, April 11, 2014
Novel approach may help to prevent false positive cardiac safety findings in new drug development.

Productive Hands Free Evaporation
Friday, April 11, 2014
Rocket™ Evaporator from Genevac provides truly unattended operation capability.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 10035
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv